EG23684A - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
EG23684A
EG23684A EG4697A EG4697A EG23684A EG 23684 A EG23684 A EG 23684A EG 4697 A EG4697 A EG 4697A EG 4697 A EG4697 A EG 4697A EG 23684 A EG23684 A EG 23684A
Authority
EG
Egypt
Prior art keywords
pharmaceuticals
Prior art date
Application number
EG4697A
Other languages
English (en)
Inventor
Michael J Greenway
Original Assignee
Smithklin Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithklin Beecham Plc filed Critical Smithklin Beecham Plc
Application granted granted Critical
Publication of EG23684A publication Critical patent/EG23684A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EG4697A 1996-01-16 1997-01-14 Pharmaceuticals EG23684A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
EG23684A true EG23684A (en) 2007-05-09

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
EG4697A EG23684A (en) 1996-01-16 1997-01-14 Pharmaceuticals

Country Status (38)

Country Link
US (1) US6765007B1 (bg)
EP (1) EP0874632B1 (bg)
JP (2) JP4711360B2 (bg)
KR (1) KR100338829B1 (bg)
CN (1) CN1132582C (bg)
AP (2) AP747A (bg)
AR (1) AR005456A1 (bg)
AT (1) ATE220910T1 (bg)
AU (1) AU713090B2 (bg)
BG (1) BG63488B1 (bg)
BR (1) BR9706982A (bg)
CY (1) CY2390B1 (bg)
CZ (1) CZ287205B6 (bg)
DE (1) DE69714215T2 (bg)
DK (1) DK0874632T3 (bg)
DZ (1) DZ2159A1 (bg)
EA (1) EA001946B1 (bg)
EG (1) EG23684A (bg)
ES (1) ES2180922T3 (bg)
GB (1) GB9600847D0 (bg)
HK (1) HK1016473A1 (bg)
HU (1) HU225472B1 (bg)
IL (1) IL124913A0 (bg)
MX (1) MX9805713A (bg)
MY (1) MY127527A (bg)
NO (1) NO315689B1 (bg)
NZ (1) NZ326769A (bg)
OA (1) OA10812A (bg)
PE (1) PE35498A1 (bg)
PL (1) PL187291B1 (bg)
PT (1) PT874632E (bg)
SK (1) SK282132B6 (bg)
TR (1) TR199800954T2 (bg)
TW (1) TW434016B (bg)
UA (1) UA63897C2 (bg)
UY (2) UY24437A1 (bg)
WO (1) WO1997025990A1 (bg)
ZA (1) ZA97310B (bg)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
KR101710148B1 (ko) 2009-06-26 2017-02-27 타리스 바이오메디컬 엘엘씨 이식가능한 약물전달 디바이스에 사용되기 위한 고체 약물 정제
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE69207656T2 (de) * 1991-01-30 1996-10-17 Wellcome Found Wasserlösliche tabletten
EP0586523A4 (en) 1991-05-15 1995-11-29 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
UY24437A1 (es) 1997-06-06
NZ326769A (en) 2000-05-26
NO315689B1 (no) 2003-10-13
HK1016473A1 (en) 1999-11-05
AP9700911A0 (en) 1997-01-31
TR199800954T2 (xx) 1998-10-21
JP2000503311A (ja) 2000-03-21
NO983259D0 (no) 1998-07-15
AP9801298A0 (en) 1998-09-30
CY2390B1 (en) 2004-09-10
CZ225498A3 (cs) 1998-12-16
US6765007B1 (en) 2004-07-20
UA63897C2 (en) 2004-02-16
BG102638A (bg) 1999-07-30
PL187291B1 (pl) 2004-06-30
HU225472B1 (en) 2006-12-28
ES2180922T3 (es) 2003-02-16
KR100338829B1 (ko) 2002-07-18
MY127527A (en) 2006-12-29
EP0874632A1 (en) 1998-11-04
GB9600847D0 (en) 1996-03-20
PT874632E (pt) 2002-10-31
KR19990077229A (ko) 1999-10-25
AP747A (en) 1999-05-03
OA10812A (en) 2003-01-29
PE35498A1 (es) 1998-08-07
JP4711360B2 (ja) 2011-06-29
DE69714215D1 (de) 2002-08-29
AU1541897A (en) 1997-08-11
EA199800573A1 (ru) 1999-02-25
EP0874632B1 (en) 2002-07-24
CN1132582C (zh) 2003-12-31
SK282132B6 (sk) 2001-11-06
CN1208350A (zh) 1999-02-17
NO983259L (no) 1998-07-15
PL327922A1 (en) 1999-01-04
UY24556A1 (es) 2001-08-27
CZ287205B6 (en) 2000-10-11
JP2009091362A (ja) 2009-04-30
ATE220910T1 (de) 2002-08-15
DE69714215T2 (de) 2003-01-23
BR9706982A (pt) 1999-07-20
HUP9901021A2 (hu) 1999-08-30
DK0874632T3 (da) 2002-11-11
AR005456A1 (es) 1999-06-23
SK95698A3 (en) 1999-01-11
AP1114A (en) 2002-10-18
AU713090B2 (en) 1999-11-25
IL124913A0 (en) 1999-01-26
HUP9901021A3 (en) 2000-08-28
MX9805713A (es) 1998-10-31
TW434016B (en) 2001-05-16
BG63488B1 (bg) 2002-03-29
WO1997025990A1 (en) 1997-07-24
DZ2159A1 (fr) 2002-12-01
ZA97310B (en) 1997-10-23
EA001946B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
GB9615202D0 (en) Pharmaceuticals
GB9601544D0 (en) Pharmaceuticals
EG23684A (en) Pharmaceuticals
GB9618967D0 (en) Pharmaceuticals
ZA972684B (en) Pharmaceuticals
GB9621183D0 (en) Pharmaceuticals
GB9606414D0 (en) Pharmaceuticals
GB9615272D0 (en) Pharmaceuticals
GB9602132D0 (en) Pharmaceuticals
GB9601546D0 (en) Pharmaceuticals
GB9615253D0 (en) Pharmaceuticals
GB9615252D0 (en) Pharmaceuticals
GB9604447D0 (en) Pharmaceuticals
GB9615274D0 (en) Pharmaceuticals
GB9615275D0 (en) Pharmaceuticals
GB9604453D0 (en) Pharmaceuticals
GB9604671D0 (en) Pharmaceuticals
GB9615276D0 (en) Pharmaceuticals
GB9617188D0 (en) Pharmaceuticals
GB9618494D0 (en) Pharmaceuticals
GB9618968D0 (en) Pharmaceuticals
GB9615273D0 (en) Pharmaceuticals
GB9604909D0 (en) Pharmaceuticals
GB9605568D0 (en) Pharmaceuticals
GB9621184D0 (en) Pharmaceuticals